Piramal Enterprises, a Mumbai, India-based business conglomerate that includes pharmaceuticals, reports that its Consumer Products Division has agreed to acquire brands from Shreya Lifescience, a Mumbai, India-based biopharmaceutical company.

This acquisition includes Shreya’s Digeplex, a digestive disorder drug, and associated brands. This acquisition adds to Piramal’s existing brands in the gastrointestinal segment, including Polycrol for reducing acidity and Naturolax, for treating constipation.

Source: Piramal